BioSpace News Archive

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow, Ph.D., Chief Executive Officer, will participate in virtual one-on-one meetings along with Denise Bevers, Chief Operating Officer, at the 20th Annual Needham Virtual Healthcare Conference

CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix management will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference taking place on April 12 – 15, 2021.

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received initial experimental results from a collaborative research agreement it entered with a large pharmaceutical company in mid-2020 to evaluate the impact of the generative chemistry technology contained in the new Artificial Intelligence-driven Drug Design (AIDD) Module in ADMET Predictor®.

The STARR Coalition, a non-profit dedicated to advancing mental health research, today announced a National Call to Action to Support Mental Health Research in partnership with biopharmaceutical research leaders, clinical investigators, and advocacy organizations focused on treating unmet mental health needs.

atai Life Sciences (“atai” or the “Company”), a global biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, has acquired a majority stake in Delaware based Psyber,

Versant Health, a leading national managed vision care company and wholly owned subsidiary of MetLife, is proud to announce Kimberly Davis as its Chief Financial Officer (CFO), effective April 1.

MedShape, Inc., the orthopedic industry leader in promoting active, adaptive healing technologies, is pleased to announce the appointment of Greg Berlet, MD as Chief Medical Officer.

New Vision Pharmaceuticals, a contract pharmaceutical development and manufacturing company specializing in blow-fill-seal packaging, has announced the availability of single-use diagnostic reagents for use in antibody and antigen COVID-19 test kits.

Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Broward Health Medical Center is establishing a robotic electrophysiology program to expand access to advanced minimally-invasive treatment of heart rhythm disorders in Florida.

PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webinar in its deep dive series discussing the PTC518 Huntington disease (HD) program on Thursday, April 15 at 9 a.m. E.T.